Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05239728 |
|---|---|
| Brief Title: | A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022) |
| First Submitted : | February 4, 2022 |
| First Submitted that Met QC Criteria : | February 4, 2022 |
| First Posted : | February 15, 2022 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |